首页> 外文期刊>Archives of disease in childhood >Vitamin K deficiency bleeding in Australian infants 1993–2017: an Australian Paediatric Surveillance Unit study
【24h】

Vitamin K deficiency bleeding in Australian infants 1993–2017: an Australian Paediatric Surveillance Unit study

机译:维生素K缺乏症澳大利亚婴儿1993-2017:澳大利亚儿科监测单元研究

获取原文
       

摘要

Objective To undertake surveillance of vitamin K deficiency bleeding (VKDB) in Australia from 1993 to 2017, during a time of change to national recommendations and available vitamin K formulations. Methods Paediatricians reported cases of VKDB in infants aged 6 months and provided demographic, clinical and biochemical information via the Australian Paediatric Surveillance Unit. Results 58 cases were reported, of which 5 (9%) were early, 11 (19%) classic and 42 (72%) late VKDB. 53 (91%) were exclusively breast fed. Seven (12%) received oral prophylaxis, the majority (86%) of whom did not receive all three recommended doses. The overall reported incidence was 0.84 per 100?000 live births (95%?CI: 0.64 to 1.08) and the incidence of late VKDB was 0.61 per 100?000 live births (95%?CI: 0.44 to 0.82), which are similar to rates reported by other countries where intramuscular vitamin K is recommended. VKDB rates were significantly higher (2.46 per 100?000 live births; 95%?CI: 1.06 to 4.85) between 1993 and March 1994 when oral prophylaxis was recommended (p0.05). Vitamin K was not given to 33 (57%) cases, primarily due to parental refusal, and the number of parental refusals increased significantly after 2006 (p0.05). There were six deaths, all due to intracranial haemorrhage, and three associated with home delivery and parental refusal of vitamin K. Conclusions Incidence rates of VKDB in Australia are among the lowest in the world; however, we have identified an increasing trend of parental refusal. Ongoing surveillance and educational campaigns for health professionals and parents are needed to prevent VKDB.
机译:目的于1993年至2017年对澳大利亚进行维生素K缺乏出血(VKDB)的目的在改变国家建议和可用的维生素K配方中。方法预订学者报告了<6个月的婴儿VKDB案例,并通过澳大利亚儿科监督单位提供人口统计学,临床和生化信息。结果报告了58例,其中5例(9%)早期,11(19%)经典和42(72%)晚期VKDB。 53(91%)独家母乳喂养。七(12%)接受口服预防,其中大多数(86%)没有收到所有三种推荐剂量。总体报告的发病率为每100 000个活产(95%?CI:0.64至1.08),vkdb的发生率为每100 000 00?000含量(95%?CI:0.44至0.82),这是相似的建议肌内维生素K的其他国家报告的利率。 VKDB率明显高于1993年至1994年3月在1993年至3月1994年间1993年至1994年间1993年至3月95%?CI:1.06至4.85)(P <0.05)。维生素K未给予33(57%)病例,主要是由于父母拒绝,父母拒绝的数量在2006年后显着增加(P <0.05)。由于颅内出血存在六种死亡,以及与家庭递送以及父母拒绝维生素K的三个死亡。结论澳大利亚VKDB的发病率是世界上最低的率;但是,我们已经确定了父母拒绝的趋势。需要持续监测和卫生专业人士和父母的教育运动,以防止VKDB。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号